Böserjunge & Zocker Forum: Community User: Böserjunge
LEXINGTON, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, is providing an additional $3.7 million in funding for the multiple-year cost-share contract between BARDA and T2 Biosystems. The total potential BARDA funding if all contract options are exercised is $62.0 million, reflecting a reduction in the scope of work under contract option 3. The additional funding will be used to advance the U.S. clinical trials for the T2Resistance® Panel and T2Biothreat® Panel and file submissions to the U.S. Food and Drug Administration (FDA) for U.S. regulatory clearance.
Mehr zu diesem Wert
|
|
Thema | ||
|---|---|---|---|
| 1 | Böserjunge & Zocker | ||
| 2 | T2 Biosystems |
|
|
Thema | ||
|---|---|---|---|
| 1 | Palantir ohne Schnickschnack | +2,31 % | |
| 2 | VONOVIA Hauptdiskussion | -0,96 % | |
| 3 | DAX Prognose / Germany 40 | -0,46 % | |
| 4 | RHEINMETALL Hauptdiskussion | -2,50 % | |
| 5 | CERES POWER Hauptdiskussion | -4,89 % | |
| 6 | Steyr Motors: Hauptdiskussion zur Aktie | +21,28 % | |
| 7 | Ulis leckere Gerresheimer Trüffel | +5,95 % | |
| 8 | SAP Hauptdiskussion | +0,60 % | |
| 9 | Vivoryon Therapeutics | -7,66 % | |
| 10 | ROCK TECH LITHIUM Hauptdiskussion | -13,79 % | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | Palantir ohne Schnickschnack | +2,31 % | |
| 2 | VONOVIA Hauptdiskussion | -0,96 % | |
| 3 | RHEINMETALL Hauptdiskussion | -2,50 % | |
| 4 | CERES POWER Hauptdiskussion | -4,89 % | |
| 5 | Steyr Motors: Hauptdiskussion zur Aktie | +21,28 % | |
| 6 | Ulis leckere Gerresheimer Trüffel | +5,95 % | |
| 7 | Vivoryon Therapeutics | -7,66 % | |
| 8 | ROCK TECH LITHIUM Hauptdiskussion | -13,79 % | |
| 9 | SAP Hauptdiskussion | +0,60 % | |
| 10 | Investmentchancen | +1,52 % | Alle Diskussionen |